AMY FREEMAN: Open Payments
NPI 1295372233 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,814 in 102 payments from 20 companies in 2025. Trend: 2023 $1,739 · 2024 $1,651 · 2025 $1,814
Food & beverage: $1,814
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $300 |
| UCB, Inc. | 13 | $288 |
| Novartis Pharmaceuticals Corporation | 13 | $210 |
| SpringWorks Therapeutics, Inc. | 11 | $201 |
| PFIZER INC. | 13 | $139 |
| Biogen, Inc. | 4 | $98 |
| Neurelis, Inc. | 4 | $90 |
| Lundbeck LLC | 4 | $90 |
| TG Therapeutics, Inc. | 3 | $81 |
| Genentech USA, Inc. | 3 | $49 |
Products named: KESIMPTA, Rystiggo, GOMEKLI, NURTEC ODT, QULIPTA, VUMERITY, VALTOCO, VYEPTI.
Industry payments across AR — which companies pay providers there.
